Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications (English)
- New search for: Touyz, R. M.
- New search for: Schiffrin, E. L.
- New search for: Touyz, R. M.
- New search for: Schiffrin, E. L.
In:
VASCULAR PHARMACOLOGY
;
45
, 1
;
19-28
;
2006
-
ISSN:
- Article (Journal) / Print
-
Title:Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
-
Contributors:Touyz, R. M. ( author ) / Schiffrin, E. L. ( author )
-
Published in:VASCULAR PHARMACOLOGY ; 45, 1 ; 19-28
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2006-01-01
-
Size:10 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 612.13
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 612.13 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 45, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
IntroductionDobrian, A. D. et al. | 2006
- 3
-
Vascular effects of TZDs: New implicationsBlaschke, F. / Spanheimer, R. / Khan, M. / Law, R. E. et al. | 2006
- 19
-
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implicationsTouyz, R. M. / Schiffrin, E. L. et al. | 2006
- 29
-
Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patientsPanunti, B. / Fonseca, V. et al. | 2006
- 36
-
The complex role of PPARγ in renal dysfunction in obesity: Managing a Janus-faced receptorDobrian, A. D. et al. | 2006
- 46
-
Can PPARγ agonists have a role in the management of obesity-related hypertension?Chetty, V. T. / Sharma, A. M. et al. | 2006
- 54
-
The role of PPARs in the microvascular dysfunction in diabetesVinik, A. / Parson, H. / Ullal, J. et al. | 2006
- 65
-
Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: Relation to dysregulated phosphatidylcholine metabolismPan, H. J. / Lin, Y. / Chen, Y. E. / Vance, D. E. / Leiter, E. H. et al. | 2006
- 72
-
Guide for Authors| 2006
-
Editorial Board| 2006